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Abstract
Background: The native extracellular matrix (ECM) consists of a highly complex, tissue-specific network of proteins and
polysaccharides, which help regulate many cellular functions. Despite the complex nature of the ECM, in vitro cell-based
studies traditionally assess cell behavior on single ECM component substrates, which do not adequately mimic the in vivo
extracellular milieu.
Methodology/Principal Findings: We present a simple approach for developing naturally derived ECM coatings for cell
culture that provide important tissue-specific cues unlike traditional cell culture coatings, thereby enabling the maturation
of committed C2C12 skeletal myoblast progenitors and human embryonic stem cells differentiated into cardiomyocytes.
Here we show that natural muscle-specific coatings can (i) be derived from decellularized, solubilized adult porcine muscle,
(ii) contain a complex mixture of ECM components including polysaccharides, (iii) adsorb onto tissue culture plastic and (iv)
promote cell maturation of committed muscle progenitor and stem cells.
Conclusions: This versatile method can create tissue-specific ECM coatings, which offer a promising platform for cell culture
to more closely mimic the mature in vivo ECM microenvironment.
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Introduction
The extracellular matrix (ECM) is well known to regulate cell
growth [1,2], survival and maturation/differentiation [3,4], as well
as play an important role in development [5]. Despite the complex
nature of the ECM, in vitro studies traditionally assess cell behavior
on coatings primarily consisting of single purified protein
components or directly on polystyrene tissue culture dishes. These
surfaces do not mimic the complexity of the extracellular
microenvironment and place further limitations on translating
findings from in vitro studies to the in vivo setting [1,6].
Furthermore, the advent of stem cell research has underscored
the importance of extracellular cues for the efficient differentiation
and maturation of progenitor cells. Therefore, it is important to
provide a growth platform that will allow cells to not only maintain
as much of their native morphology and function as in vivo, but also
the ability to fully mature, particularly in the case of progenitor
and stem cells. Deriving and utilizing the native ECM from
specific adult tissues could provide an ideal growth platform since
it could more appropriately emulate the mature, tissue specific in
vivo ECM microenvironment.
Typically, single purified matrix proteins from various animal
sources are adsorbed to cell culture substrates to provide a protein
coating for cell attachment, which may lead to modifications of
cellular behavior as cells lose their normal ECM microenviron-
ment. More complex coatings have been used, such as
combinations of single proteins of various collagens, fibronectin,
vitronectin or laminin, and while these combinatorial signals have
been shown to affect cell behavior [7,8], they do not completely
recapitulate the in vivo ECM in terms of the tissue-specific
combinations and/or ratios of various proteins and polysaccha-
rides. Cell-derived matrices have also been used, such as fibroblast
treated plates [9,10,11,12,13] and Matrigel
TM [14] coatings, but
they do not mimic any specific native tissue composition. Also,
fibroblast pretreated culture platforms have the disadvantage that
fibroblasts need to be cultured for several days to deposit matrix
[13], and then removed using trypsin prior to using the substrate
for cell culture [11,13]. In general, cells tend to maintain better
function on cell-derived matrices, thus providing support for a
more in vivo-like approach.
While many ECM components are similar, each tissue or organ
has a unique composition [15,16,17], and a tissue-specific source
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allowing for tissue-specific cellular development and maturation.
The use of tissue-specific coatings has been recently explored
[18,19]; however, limited to no effect was seen on cellular
differentiation and morphology when comparing these tissue
specific coatings to a conventional collagen coating. In this case,
the processing to obtain the material coatings resulted in removal
of glycosaminoglycans (GAGs) [18] and potentially other impor-
tant ECM components. GAGs are sugar residues linked to the
core protein of proteoglycans [20], and have been shown to be
pivotal for myoblast differentiation [21,22]. Therefore their
omission could have resulted in the little differences observed.
We have previously reported the use of tissue derived ECM as
an injectable scaffold for myocardial tissue engineering [23]. In
this work, we present a simple method to generate abundant
tissue-specific substrate coatings, which retain a complex mixture
of ECM proteins, peptides, and GAGs. We further demonstrate
the biological activity of the ECM coatings to sustain and promote
cell differentiation using two cell culture models: differentiation of
the C2C12 mouse myoblast cell line and maturation of human
stem cell derived cardiomyocytes. Our results show that these
coatings promote committed muscle progenitor differentiation and
stem cell maturation in vitro when compared to cells grown on
traditional cell culture coatings.
Methods
All experiments in this study were performed in accordance
with the guidelines established by the Animal Care and Use
Program at the University of California, San.
Diego and the American Association for Accreditation of
Laboratory Animal Care, and were approved by the Institutional
Animal Care and Use Committee at UCSD (A3033-01).
Decellularization of skeletal and cardiac tissue for matrix
coatings
Hearts and skeletal muscle from the intercostal muscles were
harvested from approximately 30–45 kg pigs, which were
anesthetized with ketamine (25 mg/kg) and xylazine (2 mg/kg)
followed by euthanasia with Pentobarbital (90 mg/kg). Connec-
tive tissue and fat was removed from the skeletal muscle, and the
major vessels and atria were removed from the heart. The tissue
was then cut into ,1c m
3 pieces, and decellularized as previously
published [23]. Briefly, the tissue was rinsed with deionized water
and then stirred in 1% (wt/vol) solution of sodium dodecyl sulfate
(SDS) in phosphate buffered saline (PBS) for 4–5 days.
Decellularized skeletal muscle and cardiac tissue was stirred
overnight in deionized water to remove the detergent. A sample
of decellularized matrix was frozen in Tissue Tek O.C.T. freezing
medium, sectioned into 10 mm slices, and stained with hematox-
ylin and eosin (H&E) to confirm the absence of cells. Following
the decellularization protocol, the ECM was lyophilized over-
night and milled using a Wiley Mini Mill to create a fine-grained
powder.
Preparation of solubilized skeletal muscle and cardiac
matrix for coating
In order to obtain a suspension appropriate for coating plates,
the milled form of the matrix was solubilized through enzymatic
digestion [23,24]. Pepsin (SIGMA, St. Louis, MO) was dissolved in
0.1 M hydrochloric acid (HCl) to make a concentration of 1 mg/
ml. Approximately 10 mg of the ECM was digested in 1 mL of
pepsin solution under constant stirring. After approximately
48 hours, the matrix was diluted using 0.1 M acetic acid to make
a 1–2.5 mg/ml concentration of skeletal muscle and cardiac ECM
solutions. These solutions were used to coat tissue culture
polystyrene for 1 h at 37uC, followed by rinsing with PBS.
Characterization of skeletal muscle and cardiac matrix
Retained biochemical cues were confirmed using assays for
protein and peptide content (SDS-PAGE, mass spectrometry), and
polysaccharide content (Blyscan). Solubilized skeletal muscle and
cardiac matrix solutions were analyzed by SDS-PAGE and
compared to rat tail collagen type I (BD Biosciences, San Jose,
CA), as previously described [23]. To determine sulfated
glycosaminoglycan (GAG) content, the Blyscan assay (Biocolor,
United Kingdom) was used per manufacturer’s instructions.
Samples were run in triplicate and averaged. Rat tail collagen
served as a negative control for the glycosaminoglycan content
determination. To more fully characterize the protein content of
the cardiac matrix and skeletal matrix, tandem mass spectroscopy
(MS/MS) was performed. Matrix samples were digested using
trypsin and analyzed by liquid chromatography (LC)-MS/MS
with electrospray ionization. A QSTAR-Elite hybrid mass
spectrometer (AB/MDS Sciex) that is interfaced to a nanoscale
reversed-phase high-pressure liquid chromatograph (Tempo) using
a 10 cm-180 ID glass capillary packed with 5-mm C18 ZorbaxTM
beads (Agilent). The buffer compositions were as follows. Buffer A
was composed of 98% H2O, 2% acetonitrile (can), 0.2% formic
acid, and 0.005% trifluoroacetic acid (TFA); buffer B was
composed of 100% ACN, 0.2% formic acid, and 0.005% TFA.
Peptides were eluted from the C-18 column into the mass
spectrometer using a linear gradient of 5–60% Buffer B over
60 min at 400 ul/min. LC-MS/MS data were acquired in a data-
dependent fashion by selecting the 4 most intense peaks with
charge state of 2 to 4 that exceeds 20 counts, with exclusion of
former target ions set to ‘‘360 seconds’’ and the mass tolerance for
exclusion set to 100 ppm. Time-of-flight MS were acquired at m/z
400 to 1600 Da for 1 s with 12 time bins to sum. MS/MS data
were acquired from m/z 50 to 2,000 Da by using ‘‘enhance all’’
and 24 time bins to sum, dynamic background subtract, automatic
collision energy, and automatic MS/MS accumulation with the
fragment intensity multiplier set to 6 and maximum accumulation
set to 2 s before returning to the survey scan. Peptide
identifications were made using paragon algorithm executed in
Protein Pilot 2.0 (Life Technologies). Proteins were labeled based
on at least one identified peptide with the confidence of above
99% for that peptide identification.
Confirmation of cardiac and skeletal muscle matrix
adsorption
1 mg/ml cardiac matrix, skeletal muscle matrix, or collagen
suspended in 0.1 M acetic acid was adsorbed onto tissue culture
plastic for 1 h at 37uC, followed by rinsing with PBS. The total
protein and peptide adsorption content was measured using a
micro BCA assay (Pierce, Rockford, IL). The amount of adsorbed
protein and peptide was determined by calculating the difference
in the coating solutions pre- and post-coating.
The presence of GAGs on the coated tissue culture plastic was
confirmed by staining the surfaces with toluidine blue (0.15 mg/
mL in 50 mM sodium acetate) for 10 minutes [25]. After
incubation with toluidine blue, the cardiac matrix, skeletal muscle
matrix, collagen, and uncoated plates were rinsed with PBS and
assessed for blue staining with brightfield microscopy.
Time of flight secondary ion mass spectroscopy (ToF-SIMS) was
also utilized to confirm adsorption of the complex matrices. Tissue
culture dishes were coated with skeletal muscle matrix, cardiac
matrix, or collagen at 1 mg/ml for 1 h at 37uC, rinsed twice with
Extracellular Matrix Coatings
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NY) for analysis. ToF-SIMS spectra were acquired on an ION-
TOF ToF.SIMS 5-300 spectrometer with a 25 keV liquid metal
ion source using Bi3
+ primary ions in the bunched mode to achieve
high mass resolution (Tascon USA, Inc., Chestnut Ridge, NY).
Spectra were acquired for positive secondary ions over a mass
range of m/z from 0–800 for evaluation of peak intensities of
amino acids fragment ions. The target current used was 0.15 pA,
and the area analyzed was approximately 1506150 um
2. Mass
resolution for a typical spectrum was approximately 6000 at m/
z=44 u (C2H6N
+). Two reads were performed on two samples for
each of the coatings, and two reads were measured on an uncoated
tissue culture plate for reference. To emphasize differences in the
coatings, relative peak intensities were normalized to the intensity
of C2H3+.
Cell Culture
C2C12 skeletal myoblasts (ATCC, Manassas, VA) were
maintained on collagen coated plates in growth media consisting
of DMEM (Gibco, Grand Island, NY) supplemented with 10%
Fetal Bovine Serum (FBS) and 1% penicillin/streptomycin (Gibco,
Grand Island, NY), and split 1:8 using trypsin when 80%
confluent. Myoblasts were diluted to a concentration of 10
7
cells/ml, and 100 ı `l was placed in wells in a 96 well plate pre-
coated with either skeletal muscle matrix or collagen, in triplicate,
to achieve 100% confluency. At 24 h, non-attached cells were
removed with a change of growth media. Cells were cultured in
growth media for the extent of the experiment in order to analyze
differences in differentiation on the surface coating without any
induction media.
Human embryonic stem cells (hESCs, HES2, ESI International)
were differentiated into beating embryoid bodies as previously
described [26] and maintained after Day 18 of differentiation in
induction medium (IM) consisting of Stempro34 (Gibco, Grand
Island, NY), 1% glutamine, 150 ug/ml transferrin (Roche,
Indianapolis, IN), 50 ng/ml L-Ascorbic Acid (SIGMA), 42 ng/
ml monothioglycerol (SIGMA), 10 ng/ml hVEGF (R&D systems,
Minneapolis, MN), 5 mg/ml bFGF (R&D systems, Minneapolis,
MN). At 35 and 112 days post differentiation, beating embryoid
bodies were dissociated by incubation with collagenase Type I
(SIGMA, St. Louis, MO) containing 10 ug/ml DNase (Calbio-
chem, San Diego, CA) for 1 h, followed by washing in Iscove’s
Modified Dulbecco’s Medium (IMDM) and incubation with
trypsin/EDTA (SIGMA, St. Louis, MO) for 10 min. Trypsin
was inactivated with FBS containing 30 mg/ml of DNase. After
incubation with these enzymes mechanical dissociation of
embryoid bodies was achieved by drawing the cell suspension
through a 20-gauge syringe needle 4–5 times. Cells were then
washed in IMDM and pelleted at 1500 rpm for 5 min. Cell pellets
were resuspended in IM media and plated onto cardiac matrix or
gelatin coated plates, in triplicate, at a density of 123610
5 cells
per 35 mm dish (0.1% solution of porcine gelatin, SIGMA, St.
Louis, MO)
Immunohistochemistry
C2C12 skeletal myoblasts were fixed with 4% paraformalde-
hyde, incubated with anti-myosin (skeletal, fast) heavy chain
(MHC) (1:200, SIGMA, St, Louis, MO), and then stained with a
secondary antibody (1:200; Invitrogen, Carlsbad, CA) and
Hoechst 33342 (1 ı `g/ml Invitrogen, Carlsbad, CA). hESC
cultures were fixed with 4% paraformaldehyde and incubated
with primary antibodies against titin M8 (1:100, kind gift from
Dr. M. Gautel, King’s College London, UK), sarcomeric a-
actinin (1:300, A7811, SIGMA, St. Louis, MO), and desmoplakin
(1:100, 2722–5204 AbD Serotec, UK). Cells were then stained
with secondary antibodies (1:250; Jackson Immunoresearch, PA)
and Hoechst 33342 stain (1 mg/ml, Invitrogen, Carlsbad, CA),
followed by visualization of signals by confocal imaging. Image
analysis was performed with Axio-Vision image processing
software. Percent differentiation of myoblasts was determined as
the number of nuclei in MHC positive cells divided by the total
number of nuclei. Five evenly spaced measurements were taken
along each myotube to determine myotube width. Average
number of nuclei per MHC positive myotube was also
determined. For hESC derived cardiomyocytes, average cardio-
myocyte cluster area was measured by determining the area of
titin M8 positive clusters, and nuclei per cluster was recorded.
Average desmoplakin size was determined by measuring pixel
area of individual desmoplakin clusters as an indicator of
desmosome formation.
Statistical analysis
All data is presented as the mean 6 standard error. For the
Blyscan assay, samples were run in triplicate and results averaged,
and reported using standard deviation. Significance was deter-
mined using a two-tailed student’s t-test, and reported as *p,0.05
and **p,0.01.
Results
Fabrication of matrix coatings
In order to fabricate the decellularized matrix coatings, ECM
was extracted from adult tissues and then processed to create a
solubilized mixture of native ECM components that was adsorbed
onto tissue culture plastic for cell culture. Figure 1 shows the
simplified protocol to achieve solubilized ECM from striated
muscle tissue. We have used the same protocol to obtain
solubilized ECM from a variety of other tissues including liver
and brain (data not shown). To isolate the matrix from adult
porcine organs, tissues were decellularized using the detergent
sodium dodecyl sulfate (SDS). Adult skeletal and cardiac muscle of
porcine origin was cut into cubes approximately 1 cm
3, rinsed
briefly using deionized water, and decellularized with 1% SDS in
phosphate buffered saline (PBS) until tissue was completely white
and then rinsed thoroughly to remove detergents. Tissue sections
were frozen, sectioned and then stained using hematoxylin and
eosin (H&E), as shown by an absence of nuclei (Figure 2a,b). After
confirmation of decellularization, the matrix was lyophilized and
milled into a fine powder, solubilized through enzymatic digestion
using pepsin [23,24], and kept at acidic pH to prevent self-
assembly (Figure 1).
Characterization of solubilized decellularized matrix
Assays for biochemical composition demonstrated that the
solubilized muscle matrix coatings retained complex biochemical
cues, including proteins, peptides, and polysaccharides. As a first
step in demonstrating that the solubilized matrix was composed of
a complex milieu of proteins and peptides, we performed PAGE.
The solubilized matrices exhibited bands that corresponded to
collagen, as expected, in addition to the presence of lower
molecular weight bands (Figure 2c). We also performed more
detailed characterization through mass spectroscopy to identify the
components within the material. Interestingly, the results indicated
that the components of cardiac matrix originated from a mixture
of collagens ranging from collagen I to collagen VI, as well as
elastin, fibrinogen, fibronectin and laminin, components expected
to be found in the myocardial ECM. In addition, fibrillin-1, a
glycoprotein found in elastic fibers, and lumican, a keratan sulfate
Extracellular Matrix Coatings
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doi:10.1371/journal.pone.0013039.g001
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Skeletal muscle matrix components contained a mixture of
collagen I, II, V, VI, VIII, XI, XII, and XIII. Mass spectroscopy
also identified fibrinogen, fibrillin-1, fibulin-5, and the proteogly-
cans lumican, dermatopontin, and decorin. Proteoglycans can
influence cell behavior, and dermatopontin and decorin in
particular play a role in matrix assembly, growth factor signaling
and myoblast differentiation [27,28,29,30]. Furthermore, our
solubilized ECM contained heparan sulfate (HS) GAGs, which
play an important role processes such as development and
angiogenesis [31,32], and are also implicated in muscle regener-
ation [21]. However, this methodology is not all-inclusive and,
therefore, there may be other extracellular matrix components
that were not identified. Using a Blyscan assay we also found that
our process allowed for the retention of GAGs, which have been
shown to be vital for skeletal myoblast differentiation [21,22]. The
solubilized skeletal muscle matrix contained 16.760.1 mg GAG
per mg of matrix, while the cardiac matrix had approximately
20 mg GAG per mg of matrix as previously reported [23]. The
retention of tissue specific components demonstrates that while the
3D structure of the original ECM is lost with this method, many of
the original biochemical cues are retained and thus these materials
may mimic the subtle complexities of each tissue’s ECM.
Surface characterization of ECM coatings
To ensure that the muscle matrices could be adsorbed onto
tissue culture plastic, we quantified the amount of protein/peptide
adsorbed, verified the presence of GAGs on the surface, and
assessed compositional differences using ToF-SIMS. The amount
of protein that adsorbed to the tissue culture plastic was measured
using a micro BCA assay, which calculates the remaining protein/
Figure 2. Characterization of cardiac and skeletal muscle matrix. (a) H&E section of decellularized cardiac ECM (b) H&E section of
decellularized skeletal muscle ECM (c) PAGE separation of the digested samples compared to collagen I. Note the more complex protein and peptide
composition in the muscle matrices.
doi:10.1371/journal.pone.0013039.g002
Table 1. Mass spectroscopy composition analysis.
Cardiac Matrix Skeletal Muscle Matrix
Collagen I X X
Collagen II X X
Collagen III X
Collagen IV X
Collagen V X X
Collagen VI X X
Collagen VIII X
Collagen XI X
Collagen XII X
Collagen XIII X
Elastin X
Fibrinogen X X
Fibronectin X
Laminin X
Fibrillin-1 X X
Lumican X X
Fibulin-3 X
Fibulin-5 X X
Heparan Sulfate X
Dermatopontin X
Decorin X
doi:10.1371/journal.pone.0013039.t001
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protein/peptide in solution pre- vs. post-adsorption was calculated
to be 17.461.5 mg/ml for skeletal muscle matrix and
27.461.3 mg/ml for cardiac matrix, with collagen measuring at
18.3560.5 mg/ml. This translates roughly to 0.05-0.09 mg protein
adsorbed per mm
2 of tissue culture plastic. Additionally, GAG
adsorption to the tissue culture plastic was demonstrated by
incubating the coated surfaces with toluidine blue [33]. The
cardiac and skeletal matrix coated surfaces remained blue after
PBS rinse, whereas the collagen and uncoated dishes were clear
(data not shown).
We further employed ToF-SIMS (time of flight secondary ion
mass spectroscopy) to analyze cardiac matrix- and skeletal matrix-
coated polystyrene dishes compared to collagen-coated and
uncoated controls. A previously published peak list [34], which
includes peak characteristics of unique amino acid mass
fragmentation patterns created from a model of ECM protein
surfaces, was chosen for ToF-SIMS. These peaks correspond to
amino acids, which are matched to common ECM proteins
[34,35,36] (Table 2). Principal Component Analysis (PCA) was
used to highlight any differences in the matrix coatings; PCA is a
mathematical analysis technique that can be used to characterize
the differences between a large set of data by calculating the
principal components (PC) [37]. The analysis revealed that there
existed distinct differences between the compositions of cardiac
matrix-, skeletal muscle matrix-, collagen-coated surfaces, and the
uncoated control due to the clustering of the data when PC2 was
graphed against PC1 (Figure 3). Most of these differences occurred
along PC1 (85%) while PC2 accounted for 6% of the differences.
To further demonstrate that the muscle matrix coatings were
more complex than simply collagen and GAGs, we examined
individual peaks based on the corresponding amino acid and ECM
protein. Both matrix coatings contained peaks associated with
amino acids found in fibronectin and laminin as well as collagen
(Figure 4). Thus, these studies confirmed that the tissue specific
coatings adsorbed to the surface of tissue culture plastic, and were
more complex than collagen. Moreover, cardiac matrix and
skeletal muscle matrix coatings were distinct from each other.
Enhanced C2C12 cell differentiation on skeletal matrix
coating
C2C12 skeletal myoblasts are a well-characterized myogenic
cell line capable of differentiation by fusion into multinucleated
myotubes [38]. These cells were expanded in growth media,
without any components to induce differentiation, and then plated
on culture plates coated with either skeletal muscle matrix or
collagen. The number of myotubes at 7 days of differentiation was
unchanged in cells grown on solubilized native ECM as compared
to collagen (data not shown). However C2C12 myoblasts cultured
on native ECM differentiated earlier (day 3, p,0.05), and had
increased fiber diameter and fusion index (p,0.01) (Figure 5).
Figure 5 displays images of myotube formation from day 3 after
plating. As the main component in both coatings was collagen, the
formation of larger, more nucleated myotubes and increased
earlier differentiation on the tissue specific matrix illustrates that
ECM components other than collagen in the skeletal muscle
matrix retained biological activity and have an important effect on
C2C12 skeletal myoblast differentiation.
Enhanced hESC-derived cardiomyocytes cell maturation
on cardiac matrix coating
While differentiation of hESCs into cardiomyocytes is routinely
achieved, maturation beyond a fetal phenotype has not been
readily achieved [39,40,41,42]. We therefore pre-committed
hESCs to cardiomyocytes and examined whether an adult cardiac
matrix coating could further promote maturation of these cells,
compared to gelatin. Gelatin was chosen as the comparison
coating, as it is the standard substrate for many differentiation
protocols with hESCs [26,43,44]. Of the mixed population, only
cells that were positively stained for Titin M8 were assessed, as
Titin M8 is a late cardiac muscle-specific marker. Cells were also
stained for desmoplakin, and nuclei. Desmoplakin is a cell-cell
junction protein that displays a punctate distribution along the
sarcolemma during cardiac muscle development, but eventually
localizes to the lateral ends of muscle cells at the intercalated disc
to form functional intercellular junction structures known as
desmosomes, which are important for cell maturation and
mechanical and structural integrity [45,46,47]. Desmosomes also
participate in morphogenesis and differentiation [48], and we
therefore used desmoplakin, a key component of the desmosomal
complex, as a marker to assess whether the cardiac matrix coating
would promote a more mature phenotype. hESC-CMs displayed
striking differences on the cardiac matrix when compared to
gelatin (Figure 6), namely an increased multi-cellular organization
and maturation. hESC-CMs were found to organize into multi-
cellular clusters as indicated by a significant increase in
myofibrillar area and number of cardiomyocyte nuclei per cell
cluster area when plated on the cardiac matrix compared to
gelatin. While there were no differences in the localization of
desmoplakin at day 35, at day 112 the immunostaining
demonstrated that desmoplakin organized and aggregated to form
large localized areas at the lateral/transverse ends between the
cardiomyocytes plated on the cardiac matrix, resembling the
intercalated disc localization of desmosomal proteins found in fully
mature cardiomyocytes in vivo [46]. Hence, there was more mature
localization of the desmosomal cell-cell junction protein, indicating
increased maturation. It should be noted that similar changes in
the spatiotemporal patterns of cardiac intercalated disc proteins
have been observed during postnatal development and maturation
of the human ventricular myocardium [49].
Discussion
There is a compelling need for the development of coating
materials that mimic the native cellular microenvironment for
better in vitro assays and for the expansion of cells for cell-mediated
therapies. In addition, a culture platform where cells are
surrounded by an environment that more closely resembles the
native ECM niche would improve the assessment of cell behavior
in other areas of research such as drug development applications.
There has been a shift of cell culture substrates from single purified
proteins, to more complex materials that attempt to mimic the
complex native ECM [9]. Combinations of purified proteins have
been shown to improve cell proliferation and differentiation,
demonstrating that complex coatings are beneficial [9,50].
However, there are many potential combinations, and using a
natural matrix would be more physiologically relevant.
In this study, we have presented a method to create matrix
coatings derived from porcine adult tissues, performed analysis to
determine the components of the solubilized extracellular matrix,
and then ensured that the surface composition retained its
complexity after adsorption onto tissue culture plastic. We
hypothesized that these coatings would have a beneficial effect
within 2D muscle culture systems as they more appropriately
emulate the native muscle ECM in vitro. This culture substrate
would thus allow for desirable cell-matrix interactions and provide
a better platform for cell phenotype and differentiation, similar to
Extracellular Matrix Coatings
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e13039that found in vivo. A potential limitation, however, of this approach
is that these matrices are of porcine origin, which has the potential
for disease transmission and immune recognition. However, the
FDA has approved many decellularized xenogeneic ECMs for
implantation including porcine dermis, small-intestine submucosa,
and heart valves [51] and therefore, we anticipate that these
Table 2. ToF-SIMS composition analysis (adapted from [34,35,36]).
Peak Number Molecular Fragment Prevalent Amino Acid Extracellular Matrix Association
1C H 4N Gly Collagen I
2C 2H4NO Gly Collagen I
3C 2H5S Met Collagen I
4C 4H6N Pro Collagen I
5C 3H6NO Gly Collagen I
6C 3H5N2O Gly Collagen I
7C 4H10SN Met Collagen I
8C 4H5N2O2 Gly Collagen I
9C 4H7N2O2 Gly Collagen I
10 C5H9SO Met Collagen I
11 C3H3O Tyr Fibronectin
12 C2H6NO Ser Fibronectin
13 C4H5O Thr Fibronectin
14 C3H3O2 Ser Fibronectin
15 C4H10N Val Fibronectin
16 C3H8NO Thr Fibronectin
17 C5H7O Val Fibronectin
18 C4H6NO Glu Fibronectin
19 C7H7O Tyr Fibronectin
20 C8H10NO Tyr Fibronectin
21 C10H11N2 Trp Fibronectin
22 C11H8NO Trp Fibronectin
23 CH3N2 Arg Laminin
24 CH5N3 Arg Laminin
25 C3H4NO Asn Laminin
26 C2H7N3 Arg Laminin
27 C2H6SN Cys Laminin
28 C4H4NO2 Asn Laminin
29 C4H10N3 Arg Laminin
30 C4H11N3 Arg Laminin
31 C5H11N4 Arg Laminin
32 C2H6N Ala, Cys
33 C4H5N2 His
34 C5H10N Lys
35 C3H7N2O Asn, Gly
36 C3H6NO2 Asp, Asn
37 C5H7N2 His
38 C5H8N3 His, Arg
39 C8H10N Phe
40 C6H5N2O His
41 C9H8O Phe
doi:10.1371/journal.pone.0013039.t002
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translation of any cells grown on these coatings, appropriate
quality control and testing will of course be essential to ensure lack
of pathogens.
The goal of this study was to demonstrate that the simple
method for fabricating naturally derived, tissue specific matrix
coatings could provide a cell culture substrate that emulates the
native ECM microenvironment, is readily available, and is as
Figure 4. Peak value data of functional groups of cardiac matrix and skeletal muscle matrix coatings. ToF-SIMS peak analysis of cardiac
matrix versus skeletal muscle matrix coated tissue culture plastic. The amino acid signatures from the peak values indicate that post adsorption the
different matrices retain their complexity with multiple ECM components. See Table 2 for individual peak descriptions.
doi:10.1371/journal.pone.0013039.g004
Figure 3. Principal component analysis of surface composition differences as detected using ToF-SIMS. PC1 versus PC2 scores plots for
cardiac matrix-, skeletal matrix-coated tissue culture plastic versus collagen coated and uncoated controls. Distinct differences are observed between
the coatings as well as the controls, indicating that both of the solubilized muscle matrices adsorbed to the surface.
doi:10.1371/journal.pone.0013039.g003
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important role in directing progenitor and stem cell differentiation
and maturation [8,52] and we thus examined the potential for
these tissue specific coatings in committed progenitor and stem cell
culture. Differentiation of muscle progenitor cells was studied
using C2C12 skeletal myoblasts on adult skeletal muscle matrix
and compared to a conventional collagen coating I [53]. To
examine the potential of the adult myocardial matrix as a coating,
we examined its effect on the morphology and maturation of
hESC derived cardiomyocytes as compared to the standard gelatin
coating typically used in stem cell derived cardiomyocyte cultures
[54,55] since we hypothesized that the adult cardiac matrix
coating could further promote maturation of these cells.
Our data shows that the native tissue matrix enhanced
differentiation of C2C12 skeletal myoblasts and maturation of
human embryonic stem cell derived cardiomyocytes when
compared to conventional cell culture coatings. While these
extracellular matrix coatings contains many biochemical cues of
the native environment, one limitation of this study is that it is
likely that some ECM components have been lost during
processing. However, the remaining matrix components do affect
cell differentiation and maturation. Skeletal muscle matrix
contains native cues that allowed for increased differentiation
and larger myotubes to develop from skeletal myoblasts when
compared to a standard single protein coating. In addition, the
cardiac matrix enhanced the formation and organization of
multicellular clusters with intercellular desmosomal like structures
resembling the cardiac intercalated disc within hESC derived
cardiomyocytes. Thus, this report highlights that the cell
microenvironment and subtle differences in matrix composition
Figure 5. C2C12 differentiation/maturation is increased on skeletal muscle matrix coating when compared to standard collagen I.
C2C12 myotube formation is shown at Day 3 on collagen I (a) or skeletal muscle matrix (b), as labeled by myosin heavy chain (red) staining, and DNA
labeled with Hoechst 33342 (blue). Percent differentiation (c), myotube width (d), and nuclei per myotube (e) were significantly increased when
myoblasts were grown on the skeletal muscle matrix coating compared to the conventional collagen coating. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0013039.g005
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method that can allow one to more closely recapitulate this
microenvironment in 2D cell culture, which could be applied to
any type of cell culture assay. Given that the origin of these
matrices is adult ECM, it is likely more applicable to terminal
differentiation/maturation and adult cell culture. There is also a
potential application for cell culture using other cell types, as to
date, we have created coatings from liver, brain, and other muscle
tissue and therefore anticipate that this process can be used to
generate substrate coatings from any non-mineralized tissue to
present the appropriate cell-matrix interactions. 3D culture
systems have recently been highlighted as a better mimic of the
in vivo environment [56], and similar matrix solutions to those
employed here as coatings can self assemble into thin films or gels
for 3D cell culture [23,24]. The 3D environment is not, however,
always suitable for all culture studies. Herein, we have developed a
simple method to produce large amounts of coating material that
would provide a better approximation of the in vivo microenvi-
ronment with the added benefit of tissue specificity and
complexity. The results of this study show the potential of
decellularized, solubilized extracellular matrix coatings derived
from muscle to promote maturation of committed progenitor and
stem cells in vitro, demonstrating this method’s applicability to
muscle cell culture; however, the general technology has wide
ranging implications.
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Figure 6. Cardiac matrix coatings increase hESC derived cardiomyocyte maturation compared to the standard gelatin substrate.
hESC-derived cardiomyocytes were cultured on gelatin (a and c) or cardiac matrix (b and d) and stained for Titin M8 (red), desmoplakin (green), or
nuclei (blue). Cell cluster area (e), number of nuclei per cluster (f), and average desmoplakin positive area (g) were measured and compared between
the two coatings. Cardiomyocytes had an increased cluster area and number of nuclei at both day 35 and 112. At day 112, the average desmoplakin
immunoreactive area was significantly greater on the cardiac matrix, with localization observed at the lateral ends of the cardiomyocytes (arrows),
indicating the formation of desmosomes and a more mature phenotype. **p,0.01.
doi:10.1371/journal.pone.0013039.g006
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